BioStock: What will Cereno Scientifics 250 MSK loan mean for the shareholders?

Following the company’s positive results from the phase II trial and pivot to fully focus on rare diseases, Cereno Scientific secured a substantial loan. Watch Sten R Sörensen, CEO talk about how this will influence the business and shareholders.

Watch the interview with Cereno Scientific at biostock.se:

https://www.biostock.se/en/2024/11/what-will-cereno-scientifics-250-msk-loan-mean-for-the-shareholders/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/